Loading clinical trials...
Loading clinical trials...
In this research study, the investigators are studying whether a reduced dose of radiation when given with standard doses of chemotherapy can reduce side effects without compromising control of the ca...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Dana-Farber Cancer Institute
NCT07419464 · Squamous Cell Carcinoma of Head and Neck, Metastatic Squamous Cell Carcinoma, and more
NCT07407569 · Human Papilloma Virus Infection Type 16
NCT06868433 · Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Metastatic Head and Neck Squamous Cell Carcinoma, and more
NCT07214584 · Cervical Cancer, Human Papilloma Virus (HPV)
NCT05495906 · HPV, Human Papilloma Virus, and more
Dana-Farber Cancer Institute
Boston, Massachusetts
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions